Loading patent…
AssigneeAbbott Laboratories
InventorsMargaret Ione Halpin Dohnalek, Karin Margaret Ostrom, Milo Duane Hilty
Estimating the term…
A method is provided for reducing the duration of diarrhea and recurrent episodes of diarrhea in humans by enterally administering indigestible oligosaccharides prophylactically. More specifically, the present invention relates to a method using indigestible oligosaccharides or fructooligosaccharides (FOS) to reduce the duration and recurrence of diarrhea in a human wherein between 0.5 grams and 5 grams of at least one FOS selected from the group consisting of 1-kestose, nystose, and 1.sup.F -.beta.-fructofuranosyl nystose is administered to said human per day. The indigestible oligosaccharides can be produced through enzymatic synthesis, chemical techniques or isolated from plant materials and are administered in the form of a nutritional product, candy, tablets, chewing gum, lozenges, milk, yogurts, fermented products and the like.
A method of reducing the duration of diarrhea in a human, said method comprises enterally administering nystose and 1.sup.F -.beta.-fructofuranosyl nystose and mixtures thereof, on a prophylactic basis to said human in an amount effective to reduce the duration of diarrhea.
A composition useful for reducing the duration of diarrhea, said composition comprising a mixture of nystose and 1.sup.F -.beta.-fructofuranosyl nystose.
A method for reducing the duration of diarrhea in a human, said method comprises enterally administering to said human at least 0.5 grams per day of a mixture of fructooligosaccharides in which the fructooligosaccharide is selected from nystose and 1.sup.F -.beta.-fructofuranosyl nystose and mixtures thereof.
Dependencies are inferred from the claim text.